Rank | Gene Set | Z-score |
---|---|---|
1 | protein K48-linked deubiquitination (GO:0071108) | 6.09918270 |
2 | monoubiquitinated protein deubiquitination (GO:0035520) | 5.42572561 |
3 | nuclear pore complex assembly (GO:0051292) | 4.99258240 |
4 | regulation of pigment cell differentiation (GO:0050932) | 4.89393462 |
5 | attachment of spindle microtubules to kinetochore (GO:0008608) | 4.87386830 |
6 | positive regulation of developmental pigmentation (GO:0048087) | 4.84385927 |
7 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.76613249 |
8 | histone mRNA catabolic process (GO:0071044) | 4.73515661 |
9 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 4.57921043 |
10 | protein K11-linked deubiquitination (GO:0035871) | 4.37343467 |
11 | cellular response to ethanol (GO:0071361) | 4.21464528 |
12 | nuclear pore organization (GO:0006999) | 4.21201216 |
13 | positive regulation of DNA-templated transcription, initiation (GO:2000144) | 4.18956451 |
14 | B cell receptor signaling pathway (GO:0050853) | 4.16870138 |
15 | regulation of cilium movement (GO:0003352) | 4.12834848 |
16 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.08441700 |
17 | microtubule anchoring (GO:0034453) | 3.99836268 |
18 | positive T cell selection (GO:0043368) | 3.95846630 |
19 | synaptic vesicle endocytosis (GO:0048488) | 3.83964338 |
20 | Peyers patch development (GO:0048541) | 3.82447774 |
21 | mucosal-associated lymphoid tissue development (GO:0048537) | 3.82447774 |
22 | establishment of mitotic spindle orientation (GO:0000132) | 3.79663057 |
23 | negative regulation of DNA repair (GO:0045738) | 3.75035655 |
24 | pore complex assembly (GO:0046931) | 3.70802183 |
25 | mitotic sister chromatid segregation (GO:0000070) | 3.68478771 |
26 | establishment of protein localization to Golgi (GO:0072600) | 3.66261140 |
27 | hepatocyte apoptotic process (GO:0097284) | 3.60879019 |
28 | histone-serine phosphorylation (GO:0035404) | 3.60593794 |
29 | establishment of spindle orientation (GO:0051294) | 3.60547494 |
30 | sister chromatid segregation (GO:0000819) | 3.59059131 |
31 | histone H3-K4 trimethylation (GO:0080182) | 3.57738546 |
32 | cytoplasmic mRNA processing body assembly (GO:0033962) | 3.55811179 |
33 | establishment of mitotic spindle localization (GO:0040001) | 3.51338954 |
34 | establishment of spindle localization (GO:0051293) | 3.37622746 |
35 | histone H3-K36 demethylation (GO:0070544) | 3.35611832 |
36 | positive regulation of growth hormone secretion (GO:0060124) | 3.28130317 |
37 | regulation of establishment of cell polarity (GO:2000114) | 3.23865762 |
38 | protein K63-linked deubiquitination (GO:0070536) | 3.22975355 |
39 | regulation of necroptotic process (GO:0060544) | 3.20905655 |
40 | negative T cell selection (GO:0043383) | 3.20900177 |
41 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.19812060 |
42 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.18256463 |
43 | positive regulation of granulocyte differentiation (GO:0030854) | 3.17330434 |
44 | negative thymic T cell selection (GO:0045060) | 3.08152700 |
45 | protein targeting to Golgi (GO:0000042) | 3.06639508 |
46 | peptidyl-lysine trimethylation (GO:0018023) | 3.06409190 |
47 | interkinetic nuclear migration (GO:0022027) | 3.06408638 |
48 | activated T cell proliferation (GO:0050798) | 3.06253340 |
49 | otic vesicle formation (GO:0030916) | 3.03847450 |
50 | positive thymic T cell selection (GO:0045059) | 3.03558857 |
51 | regulation of meiosis I (GO:0060631) | 3.03087920 |
52 | centrosome localization (GO:0051642) | 3.02867142 |
53 | regulation of gamma-delta T cell activation (GO:0046643) | 3.00812160 |
54 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.99675834 |
55 | determination of adult lifespan (GO:0008340) | 2.98463666 |
56 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.97741554 |
57 | deoxyribonucleoside diphosphate metabolic process (GO:0009186) | 2.94359902 |
58 | regulation of mRNA catabolic process (GO:0061013) | 2.93383308 |
59 | regulation of inositol phosphate biosynthetic process (GO:0010919) | 2.91578046 |
60 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.91164337 |
61 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.88463597 |
62 | regulation of protein polyubiquitination (GO:1902914) | 2.85792816 |
63 | Golgi to endosome transport (GO:0006895) | 2.85562267 |
64 | negative regulation of meiosis (GO:0045835) | 2.85468584 |
65 | positive regulation of mRNA catabolic process (GO:0061014) | 2.82052580 |
66 | B cell proliferation (GO:0042100) | 2.80801892 |
67 | mitochondrial DNA replication (GO:0006264) | 2.78579970 |
68 | microglial cell activation (GO:0001774) | 2.76956394 |
69 | establishment of nucleus localization (GO:0040023) | 2.74747415 |
70 | gamma-aminobutyric acid transport (GO:0015812) | 2.74122181 |
71 | nucleus localization (GO:0051647) | 2.72113171 |
72 | regulation of growth hormone secretion (GO:0060123) | 2.71330497 |
73 | negative regulation of B cell proliferation (GO:0030889) | 2.70604125 |
74 | protein prenylation (GO:0018342) | 2.69771517 |
75 | prenylation (GO:0097354) | 2.69771517 |
76 | protein deubiquitination (GO:0016579) | 2.69360843 |
77 | regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211) | 2.68047347 |
78 | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213) | 2.68047347 |
79 | sister chromatid cohesion (GO:0007062) | 2.67278087 |
80 | positive regulation of inositol phosphate biosynthetic process (GO:0060732) | 2.67160042 |
81 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 2.66692548 |
82 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.65915570 |
83 | regulation of DNA-templated transcription, initiation (GO:2000142) | 2.65534178 |
84 | spleen development (GO:0048536) | 2.63507361 |
85 | neuronal action potential propagation (GO:0019227) | 2.61808404 |
86 | macroautophagy (GO:0016236) | 2.61281072 |
87 | dosage compensation (GO:0007549) | 2.61128300 |
88 | necrotic cell death (GO:0070265) | 2.60710933 |
89 | polyol catabolic process (GO:0046174) | 2.60449454 |
90 | positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261) | 2.59044659 |
91 | phospholipid translocation (GO:0045332) | 2.57479045 |
92 | lipid translocation (GO:0034204) | 2.57479045 |
93 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.57456006 |
94 | snRNA transcription (GO:0009301) | 2.56347484 |
95 | nerve growth factor signaling pathway (GO:0038180) | 2.56249351 |
96 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.55941541 |
97 | regulation of MHC class I biosynthetic process (GO:0045343) | 2.54854322 |
98 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.54195806 |
99 | peptidyl-lysine methylation (GO:0018022) | 2.53991754 |
100 | negative regulation of osteoblast proliferation (GO:0033689) | 2.53765607 |
Rank | Gene Set | Z-score |
---|---|---|
1 | GATA1_22025678_ChIP-Seq_K562_Human | 4.81540533 |
2 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.56763502 |
3 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 3.45423889 |
4 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.80870377 |
5 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.75319672 |
6 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.72419656 |
7 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.62451073 |
8 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.45351201 |
9 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.42712253 |
10 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.40760999 |
11 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.40540101 |
12 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.34668045 |
13 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.22450384 |
14 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.18867958 |
15 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 2.17600535 |
16 | TP53_16413492_ChIP-PET_HCT116_Human | 2.08946648 |
17 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.08703177 |
18 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.03633302 |
19 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.02800900 |
20 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.90020992 |
21 | * ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.77398004 |
22 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.76134801 |
23 | STAT3_23295773_ChIP-Seq_U87_Human | 1.76125340 |
24 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.74768032 |
25 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.74500530 |
26 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.73183714 |
27 | FUS_26573619_Chip-Seq_HEK293_Human | 1.73031695 |
28 | * SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.71976539 |
29 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.67309528 |
30 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.65587561 |
31 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.65034681 |
32 | * ER_23166858_ChIP-Seq_MCF-7_Human | 1.63889038 |
33 | * NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.61908038 |
34 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.60819442 |
35 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.60637386 |
36 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.59581760 |
37 | * EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.59566185 |
38 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.59045717 |
39 | EWS_26573619_Chip-Seq_HEK293_Human | 1.57637725 |
40 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.57071529 |
41 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.55539255 |
42 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.51775744 |
43 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.50760496 |
44 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.49648147 |
45 | P300_19829295_ChIP-Seq_ESCs_Human | 1.46466497 |
46 | TCF4_23295773_ChIP-Seq_U87_Human | 1.43267301 |
47 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.40084643 |
48 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.39774681 |
49 | * E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.36516115 |
50 | MYB_26560356_Chip-Seq_TH2_Human | 1.34282207 |
51 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.33862388 |
52 | * EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.33393874 |
53 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.33048064 |
54 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.32920254 |
55 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.32920254 |
56 | * CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.32015948 |
57 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.30686239 |
58 | * SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.29908752 |
59 | * P53_22387025_ChIP-Seq_ESCs_Mouse | 1.29710725 |
60 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.29361225 |
61 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.26936785 |
62 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.24790253 |
63 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.24743580 |
64 | VDR_22108803_ChIP-Seq_LS180_Human | 1.23908525 |
65 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.23528787 |
66 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.22480995 |
67 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.22480995 |
68 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.21431053 |
69 | * NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.20985719 |
70 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.19933282 |
71 | * CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.18290127 |
72 | * OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.18276898 |
73 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.18231665 |
74 | * CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.17771830 |
75 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.17527003 |
76 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.16151491 |
77 | * P300_18555785_Chip-Seq_ESCs_Mouse | 1.15838738 |
78 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.15565230 |
79 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.14968654 |
80 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.13904215 |
81 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.13217373 |
82 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.12696955 |
83 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.10480348 |
84 | * EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.10441782 |
85 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.10389666 |
86 | * STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.10374296 |
87 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.08873220 |
88 | AR_25329375_ChIP-Seq_VCAP_Human | 1.08743710 |
89 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.08176046 |
90 | * OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.08036087 |
91 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 1.07323514 |
92 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.06286893 |
93 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.05075302 |
94 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.04384379 |
95 | * SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.03870866 |
96 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.03552012 |
97 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.03477909 |
98 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.03477909 |
99 | * KDM2B_26808549_Chip-Seq_REH_Human | 1.02245509 |
100 | * SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.02127856 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0000569_abnormal_digit_pigmentation | 6.06132208 |
2 | MP0008057_abnormal_DNA_replication | 5.37539379 |
3 | MP0003806_abnormal_nucleotide_metabolis | 3.46922659 |
4 | MP0008260_abnormal_autophagy | 3.24166007 |
5 | MP0000015_abnormal_ear_pigmentation | 2.82494475 |
6 | MP0003763_abnormal_thymus_physiology | 2.72862906 |
7 | MP0003656_abnormal_erythrocyte_physiolo | 2.35468858 |
8 | MP0002102_abnormal_ear_morphology | 2.19357333 |
9 | MP0005408_hypopigmentation | 2.14523480 |
10 | MP0004381_abnormal_hair_follicle | 2.10496353 |
11 | MP0003787_abnormal_imprinting | 2.09496534 |
12 | MP0001835_abnormal_antigen_presentation | 2.02115150 |
13 | MP0000372_irregular_coat_pigmentation | 2.01784479 |
14 | MP0003950_abnormal_plasma_membrane | 1.96950476 |
15 | MP0005310_abnormal_salivary_gland | 1.89463008 |
16 | MP0005645_abnormal_hypothalamus_physiol | 1.88955318 |
17 | MP0001800_abnormal_humoral_immune | 1.87465672 |
18 | MP0001501_abnormal_sleep_pattern | 1.82022907 |
19 | MP0005075_abnormal_melanosome_morpholog | 1.80163928 |
20 | MP0005671_abnormal_response_to | 1.79086526 |
21 | MP0002396_abnormal_hematopoietic_system | 1.76278254 |
22 | MP0003866_abnormal_defecation | 1.68778220 |
23 | MP0005266_abnormal_metabolism | 1.64531848 |
24 | MP0000371_diluted_coat_color | 1.62076073 |
25 | MP0002009_preneoplasia | 1.61425310 |
26 | MP0008877_abnormal_DNA_methylation | 1.56235528 |
27 | MP0005174_abnormal_tail_pigmentation | 1.55969313 |
28 | MP0002166_altered_tumor_susceptibility | 1.54692950 |
29 | MP0004147_increased_porphyrin_level | 1.52599730 |
30 | MP0005451_abnormal_body_composition | 1.52410455 |
31 | MP0009697_abnormal_copulation | 1.51990298 |
32 | MP0003221_abnormal_cardiomyocyte_apopto | 1.46437857 |
33 | MP0010386_abnormal_urinary_bladder | 1.44835854 |
34 | MP0000685_abnormal_immune_system | 1.42430891 |
35 | MP0002398_abnormal_bone_marrow | 1.36197461 |
36 | MP0003632_abnormal_nervous_system | 1.33994927 |
37 | MP0005423_abnormal_somatic_nervous | 1.33125217 |
38 | MP0003690_abnormal_glial_cell | 1.30086848 |
39 | MP0002909_abnormal_adrenal_gland | 1.24285202 |
40 | MP0009046_muscle_twitch | 1.22034119 |
41 | MP0002420_abnormal_adaptive_immunity | 1.20552647 |
42 | MP0002095_abnormal_skin_pigmentation | 1.18888845 |
43 | MP0002332_abnormal_exercise_endurance | 1.18570601 |
44 | MP0004859_abnormal_synaptic_plasticity | 1.17547542 |
45 | MP0005171_absent_coat_pigmentation | 1.17519042 |
46 | MP0005187_abnormal_penis_morphology | 1.17487066 |
47 | MP0000689_abnormal_spleen_morphology | 1.16054661 |
48 | MP0001819_abnormal_immune_cell | 1.15429304 |
49 | MP0000703_abnormal_thymus_morphology | 1.14574778 |
50 | MP0000427_abnormal_hair_cycle | 1.13360793 |
51 | MP0002452_abnormal_antigen_presenting | 1.13110738 |
52 | MP0002723_abnormal_immune_serum | 1.11071496 |
53 | MP0003183_abnormal_peptide_metabolism | 1.10363223 |
54 | MP0000716_abnormal_immune_system | 1.10031498 |
55 | MP0005386_behavior/neurological_phenoty | 1.05212741 |
56 | MP0004924_abnormal_behavior | 1.05212741 |
57 | MP0002272_abnormal_nervous_system | 1.02388557 |
58 | MP0002722_abnormal_immune_system | 1.01796075 |
59 | MP0004808_abnormal_hematopoietic_stem | 1.01764518 |
60 | MP0003091_abnormal_cell_migration | 0.99428732 |
61 | MP0003045_fibrosis | 0.97868709 |
62 | MP0010094_abnormal_chromosome_stability | 0.96908503 |
63 | MP0002877_abnormal_melanocyte_morpholog | 0.95705862 |
64 | MP0003724_increased_susceptibility_to | 0.94681938 |
65 | MP0002006_tumorigenesis | 0.91855253 |
66 | MP0003631_nervous_system_phenotype | 0.89915444 |
67 | MP0004883_abnormal_blood_vessel | 0.89893583 |
68 | MP0003077_abnormal_cell_cycle | 0.89761438 |
69 | MP0001790_abnormal_immune_system | 0.88428614 |
70 | MP0005387_immune_system_phenotype | 0.88428614 |
71 | MP0009745_abnormal_behavioral_response | 0.88399971 |
72 | MP0003635_abnormal_synaptic_transmissio | 0.88072179 |
73 | MP0002822_catalepsy | 0.86876402 |
74 | MP0005376_homeostasis/metabolism_phenot | 0.84930589 |
75 | MP0009115_abnormal_fat_cell | 0.84741280 |
76 | MP0003646_muscle_fatigue | 0.82795273 |
77 | MP0002405_respiratory_system_inflammati | 0.82093882 |
78 | MP0003172_abnormal_lysosome_physiology | 0.81919879 |
79 | MP0002429_abnormal_blood_cell | 0.81696085 |
80 | MP0004484_altered_response_of | 0.81369334 |
81 | MP0005000_abnormal_immune_tolerance | 0.80440257 |
82 | MP0005621_abnormal_cell_physiology | 0.79317848 |
83 | MP0005647_abnormal_sex_gland | 0.79261975 |
84 | MP0008058_abnormal_DNA_repair | 0.77810967 |
85 | MP0005551_abnormal_eye_electrophysiolog | 0.76573111 |
86 | MP0005248_abnormal_Harderian_gland | 0.75884146 |
87 | MP0009785_altered_susceptibility_to | 0.75701472 |
88 | MP0002067_abnormal_sensory_capabilities | 0.75661795 |
89 | MP0000465_gastrointestinal_hemorrhage | 0.75507818 |
90 | MP0002419_abnormal_innate_immunity | 0.75262350 |
91 | MP0002019_abnormal_tumor_incidence | 0.74236955 |
92 | MP0003890_abnormal_embryonic-extraembry | 0.73497739 |
93 | MP0003121_genomic_imprinting | 0.73102587 |
94 | MP0010307_abnormal_tumor_latency | 0.72574324 |
95 | MP0003868_abnormal_feces_composition | 0.72424275 |
96 | MP0002064_seizures | 0.71785704 |
97 | MP0006035_abnormal_mitochondrial_morpho | 0.70247300 |
98 | MP0003303_peritoneal_inflammation | 0.69311764 |
99 | MP0001191_abnormal_skin_condition | 0.66570037 |
100 | MP0002075_abnormal_coat/hair_pigmentati | 0.66343742 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Volvulus (HP:0002580) | 5.40994192 |
2 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 4.47548428 |
3 | Gaze-evoked nystagmus (HP:0000640) | 4.30644877 |
4 | T lymphocytopenia (HP:0005403) | 4.13302794 |
5 | Abnormality of T cell number (HP:0011839) | 3.68089487 |
6 | Progressive inability to walk (HP:0002505) | 3.36653221 |
7 | Progressive external ophthalmoplegia (HP:0000590) | 3.21212300 |
8 | Fair hair (HP:0002286) | 3.16916344 |
9 | Poikilocytosis (HP:0004447) | 3.14951727 |
10 | Bilateral sensorineural hearing impairment (HP:0008619) | 3.12803816 |
11 | Febrile seizures (HP:0002373) | 3.10778286 |
12 | Inability to walk (HP:0002540) | 3.05275706 |
13 | Hyperventilation (HP:0002883) | 3.03798887 |
14 | Papillary thyroid carcinoma (HP:0002895) | 3.02806831 |
15 | Abnormality of the renal cortex (HP:0011035) | 2.98894713 |
16 | Slow saccadic eye movements (HP:0000514) | 2.93901127 |
17 | Acanthocytosis (HP:0001927) | 2.93001874 |
18 | Inappropriate behavior (HP:0000719) | 2.89286976 |
19 | Submucous cleft hard palate (HP:0000176) | 2.87648238 |
20 | Dysmetric saccades (HP:0000641) | 2.87309238 |
21 | Blue irides (HP:0000635) | 2.86324074 |
22 | Generalized hypopigmentation of hair (HP:0011358) | 2.82289895 |
23 | Colitis (HP:0002583) | 2.77157943 |
24 | IgA deficiency (HP:0002720) | 2.74889501 |
25 | Postural instability (HP:0002172) | 2.69360126 |
26 | Genetic anticipation (HP:0003743) | 2.65684685 |
27 | Renal cortical cysts (HP:0000803) | 2.62704719 |
28 | Papilledema (HP:0001085) | 2.50523793 |
29 | Impaired vibratory sensation (HP:0002495) | 2.45604177 |
30 | Protruding tongue (HP:0010808) | 2.44776967 |
31 | Recurrent bacterial skin infections (HP:0005406) | 2.44743302 |
32 | IgM deficiency (HP:0002850) | 2.39958518 |
33 | Sensory axonal neuropathy (HP:0003390) | 2.39912432 |
34 | Progressive cerebellar ataxia (HP:0002073) | 2.36323621 |
35 | Oligodactyly (hands) (HP:0001180) | 2.35253285 |
36 | Drooling (HP:0002307) | 2.34584223 |
37 | Poor eye contact (HP:0000817) | 2.32136672 |
38 | Prominent nose (HP:0000448) | 2.31928117 |
39 | Widely spaced teeth (HP:0000687) | 2.30622808 |
40 | Acute hepatic failure (HP:0006554) | 2.29246472 |
41 | Disinhibition (HP:0000734) | 2.27771394 |
42 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.27596517 |
43 | Excessive salivation (HP:0003781) | 2.25383092 |
44 | Recurrent bronchitis (HP:0002837) | 2.23524820 |
45 | Urethral obstruction (HP:0000796) | 2.23244329 |
46 | Acute myeloid leukemia (HP:0004808) | 2.19615531 |
47 | Recurrent cutaneous fungal infections (HP:0011370) | 2.18447080 |
48 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.18447080 |
49 | Abnormality of the fingertips (HP:0001211) | 2.17512116 |
50 | Abnormality of T cells (HP:0002843) | 2.14314204 |
51 | Subacute progressive viral hepatitis (HP:0006572) | 2.14233910 |
52 | Keratoconjunctivitis (HP:0001096) | 2.12411866 |
53 | Abnormality of salivation (HP:0100755) | 2.11991881 |
54 | Autoimmune hemolytic anemia (HP:0001890) | 2.11905863 |
55 | Recurrent viral infections (HP:0004429) | 2.10725251 |
56 | Hypoplasia of the thymus (HP:0000778) | 2.10311068 |
57 | Absent speech (HP:0001344) | 2.07759277 |
58 | Keratoconjunctivitis sicca (HP:0001097) | 2.07335498 |
59 | Sandal gap (HP:0001852) | 2.06792598 |
60 | Recurrent skin infections (HP:0001581) | 2.06770893 |
61 | Tubulointerstitial fibrosis (HP:0005576) | 2.06272287 |
62 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.01779788 |
63 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.01779788 |
64 | Viral hepatitis (HP:0006562) | 2.00815605 |
65 | Truncal obesity (HP:0001956) | 2.00643152 |
66 | Thyroiditis (HP:0100646) | 1.98983489 |
67 | Short chin (HP:0000331) | 1.97777186 |
68 | Spastic gait (HP:0002064) | 1.97100323 |
69 | Tinnitus (HP:0000360) | 1.96776820 |
70 | Lower limb muscle weakness (HP:0007340) | 1.96360176 |
71 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.93764269 |
72 | Visual hallucinations (HP:0002367) | 1.93468575 |
73 | Inflammation of the large intestine (HP:0002037) | 1.92166139 |
74 | Focal motor seizures (HP:0011153) | 1.91452234 |
75 | Acute lymphatic leukemia (HP:0006721) | 1.90549218 |
76 | Abnormality of saccadic eye movements (HP:0000570) | 1.89608862 |
77 | Xerostomia (HP:0000217) | 1.88079005 |
78 | Action tremor (HP:0002345) | 1.87503939 |
79 | Atonic seizures (HP:0010819) | 1.87074879 |
80 | Abnormality of chromosome stability (HP:0003220) | 1.85045733 |
81 | Aplasia/Hypoplasia of the macula (HP:0008059) | 1.84871955 |
82 | Tented upper lip vermilion (HP:0010804) | 1.84365619 |
83 | Recurrent fungal infections (HP:0002841) | 1.83845040 |
84 | Clumsiness (HP:0002312) | 1.83471938 |
85 | Gingivitis (HP:0000230) | 1.83131281 |
86 | Ocular albinism (HP:0001107) | 1.81345225 |
87 | Chronic diarrhea (HP:0002028) | 1.80495359 |
88 | Long clavicles (HP:0000890) | 1.79802768 |
89 | Poor coordination (HP:0002370) | 1.79361700 |
90 | Spontaneous hematomas (HP:0007420) | 1.78720481 |
91 | Recurrent abscess formation (HP:0002722) | 1.77520656 |
92 | Menstrual irregularities (HP:0000858) | 1.76745325 |
93 | Hypopigmentation of the fundus (HP:0007894) | 1.76657698 |
94 | Tubulointerstitial abnormality (HP:0001969) | 1.76654991 |
95 | Spastic paraplegia (HP:0001258) | 1.74686400 |
96 | Impaired vibration sensation in the lower limbs (HP:0002166) | 1.74117493 |
97 | Mild short stature (HP:0003502) | 1.72282929 |
98 | Tubular atrophy (HP:0000092) | 1.71981271 |
99 | Thyroid carcinoma (HP:0002890) | 1.71883020 |
100 | Mask-like facies (HP:0000298) | 1.71780230 |
Rank | Gene Set | Z-score |
---|---|---|
1 | NEK2 | 4.32999098 |
2 | FRK | 3.20224046 |
3 | TYK2 | 2.08758747 |
4 | RIPK4 | 2.06815461 |
5 | NEK1 | 10.1320984 |
6 | ACVR1B | 1.81717382 |
7 | PLK4 | 1.81051319 |
8 | MAP3K4 | 1.71130955 |
9 | PLK2 | 1.69561360 |
10 | BLK | 1.68275735 |
11 | SIK2 | 1.46898850 |
12 | MAP3K6 | 1.45844271 |
13 | GRK7 | 1.44532219 |
14 | CAMKK2 | 1.41481500 |
15 | TAOK3 | 1.40511441 |
16 | SGK2 | 1.39337079 |
17 | PTK2B | 1.37856074 |
18 | BRD4 | 1.31318486 |
19 | CAMK1D | 1.30033074 |
20 | BMPR2 | 1.27034403 |
21 | TRPM7 | 1.26998730 |
22 | AKT3 | 1.24322150 |
23 | MAPK13 | 1.22527920 |
24 | CCNB1 | 1.20427940 |
25 | IKBKE | 1.19872982 |
26 | SYK | 1.14522326 |
27 | CDK12 | 1.13498557 |
28 | EIF2AK3 | 1.08354896 |
29 | STK4 | 1.07767783 |
30 | TEC | 1.05319751 |
31 | BTK | 1.03274490 |
32 | FGR | 0.99102052 |
33 | CAMK1G | 0.96965710 |
34 | TXK | 0.95736994 |
35 | PRKCH | 0.90875364 |
36 | WNK1 | 0.90725850 |
37 | HCK | 0.89163568 |
38 | MARK3 | 0.86478722 |
39 | BMPR1B | 0.85221622 |
40 | NEK6 | 0.84700064 |
41 | MAP4K2 | 0.80512267 |
42 | GRK6 | 0.78521532 |
43 | CAMK4 | 0.78512483 |
44 | SGK3 | 0.77337114 |
45 | PIK3CG | 0.74857361 |
46 | SGK223 | 0.74772552 |
47 | SGK494 | 0.74772552 |
48 | RAF1 | 0.74752284 |
49 | JAK1 | 0.74599673 |
50 | MKNK2 | 0.71937839 |
51 | PIM1 | 0.70879443 |
52 | FGFR3 | 0.69356087 |
53 | SGK1 | 0.65768019 |
54 | MAP4K1 | 0.65359359 |
55 | ITK | 0.63369651 |
56 | ERBB3 | 0.63031230 |
57 | MELK | 0.61045635 |
58 | FES | 0.58547753 |
59 | UHMK1 | 0.58376561 |
60 | SCYL2 | 0.57599883 |
61 | RPS6KB2 | 0.57409794 |
62 | OBSCN | 0.57341955 |
63 | RPS6KA5 | 0.53209992 |
64 | MAP3K2 | 0.51908218 |
65 | GRK5 | 0.51431514 |
66 | ADRBK1 | 0.50481521 |
67 | JAK2 | 0.48196960 |
68 | LYN | 0.47952925 |
69 | MAPK7 | 0.47192110 |
70 | CAMK2B | 0.45179444 |
71 | PAK3 | 0.45010612 |
72 | EGFR | 0.44578004 |
73 | RPS6KB1 | 0.43648118 |
74 | PRKCQ | 0.42286708 |
75 | KSR2 | 0.41932547 |
76 | ROCK2 | 0.41774746 |
77 | CSNK1D | 0.41640424 |
78 | JAK3 | 0.40409122 |
79 | ATM | 0.39732764 |
80 | IRAK4 | 0.39206356 |
81 | MARK2 | 0.38045209 |
82 | LCK | 0.36725380 |
83 | STK38 | 0.35268114 |
84 | MAPKAPK5 | 0.34978019 |
85 | NEK9 | 0.34606316 |
86 | CSK | 0.34213345 |
87 | CAMKK1 | 0.34061386 |
88 | PRKACB | 0.33444413 |
89 | PDGFRB | 0.32865264 |
90 | MAP3K10 | 0.30764535 |
91 | MAPK10 | 0.30668688 |
92 | MAP3K14 | 0.30041350 |
93 | RPS6KA4 | 0.29647822 |
94 | PRKAA2 | 0.28883280 |
95 | ERBB2 | 0.27431137 |
96 | MAPK11 | 0.26863719 |
97 | PRKCB | 0.26578817 |
98 | TNIK | 0.25638814 |
99 | DYRK1A | 0.25043905 |
100 | KSR1 | 0.24682920 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 2.62634775 |
2 | Nicotine addiction_Homo sapiens_hsa05033 | 2.32767462 |
3 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 2.25994684 |
4 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 2.21350847 |
5 | Taste transduction_Homo sapiens_hsa04742 | 2.15861878 |
6 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.15465507 |
7 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.88310637 |
8 | Alcoholism_Homo sapiens_hsa05034 | 1.88154172 |
9 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.85188102 |
10 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.74067562 |
11 | Long-term potentiation_Homo sapiens_hsa04720 | 1.60293989 |
12 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.57475109 |
13 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.53796124 |
14 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.50432728 |
15 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.48947071 |
16 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.43244173 |
17 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.41594956 |
18 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.39600867 |
19 | Measles_Homo sapiens_hsa05162 | 1.34877775 |
20 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.29457379 |
21 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.28190351 |
22 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.25072000 |
23 | Hepatitis B_Homo sapiens_hsa05161 | 1.23933331 |
24 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.20412194 |
25 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.19322329 |
26 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.16895424 |
27 | FoxO signaling pathway_Homo sapiens_hsa04068 | 1.16319043 |
28 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.14559437 |
29 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 1.11516224 |
30 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.11404555 |
31 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.04736094 |
32 | Morphine addiction_Homo sapiens_hsa05032 | 1.03352999 |
33 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.02864409 |
34 | Leishmaniasis_Homo sapiens_hsa05140 | 0.99549810 |
35 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.97762766 |
36 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.97290081 |
37 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.93466424 |
38 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.92763984 |
39 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.91925716 |
40 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.91351694 |
41 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.91091470 |
42 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.90836415 |
43 | Platelet activation_Homo sapiens_hsa04611 | 0.90247781 |
44 | Long-term depression_Homo sapiens_hsa04730 | 0.90019335 |
45 | Glioma_Homo sapiens_hsa05214 | 0.89801807 |
46 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.89331403 |
47 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.89029245 |
48 | Allograft rejection_Homo sapiens_hsa05330 | 0.88886640 |
49 | Tuberculosis_Homo sapiens_hsa05152 | 0.87833296 |
50 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.86278259 |
51 | Hepatitis C_Homo sapiens_hsa05160 | 0.85787605 |
52 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.85264553 |
53 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.83799193 |
54 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.82667904 |
55 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.82663422 |
56 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.81627856 |
57 | Salivary secretion_Homo sapiens_hsa04970 | 0.81570781 |
58 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.80818939 |
59 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.80801187 |
60 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.80049027 |
61 | Influenza A_Homo sapiens_hsa05164 | 0.79874938 |
62 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.79857985 |
63 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.78847701 |
64 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.78028773 |
65 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.77705492 |
66 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.75051650 |
67 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.74068455 |
68 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.73741972 |
69 | RNA degradation_Homo sapiens_hsa03018 | 0.73514715 |
70 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.73266964 |
71 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.72969325 |
72 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.72791963 |
73 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.72275762 |
74 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.72180233 |
75 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.71948656 |
76 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.71339121 |
77 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.71309332 |
78 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.70625918 |
79 | Cell cycle_Homo sapiens_hsa04110 | 0.68971205 |
80 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.68552291 |
81 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.68354772 |
82 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.68251538 |
83 | Prostate cancer_Homo sapiens_hsa05215 | 0.67490924 |
84 | ABC transporters_Homo sapiens_hsa02010 | 0.66268178 |
85 | Colorectal cancer_Homo sapiens_hsa05210 | 0.65486314 |
86 | Olfactory transduction_Homo sapiens_hsa04740 | 0.65322354 |
87 | Endometrial cancer_Homo sapiens_hsa05213 | 0.65277812 |
88 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.64955213 |
89 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.64753720 |
90 | GABAergic synapse_Homo sapiens_hsa04727 | 0.64227171 |
91 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.63671520 |
92 | Circadian entrainment_Homo sapiens_hsa04713 | 0.63178641 |
93 | Apoptosis_Homo sapiens_hsa04210 | 0.62567641 |
94 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.58717286 |
95 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.58681257 |
96 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.57309206 |
97 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.55237338 |
98 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.55133552 |
99 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.55073326 |
100 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.54792662 |